SCOPUS 정보 검색 플랫폼

Blood

Volumn 110, Issue 3, 2007, Pages 1075-1076

Lenalidomide therapy in a patient with POEMS syndrome [4]

(3) Dispenzieri, Angela a Klein, Christopher J b Mauermann, Michelle L b

a MAYO CLINIC (United States)

b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; DEXAMETHASONE; INTERLEUKIN 6; LENALIDOMIDE; VASCULOTROPIN;

ADULT; AFRICAN AMERICAN; CASE REPORT; DAILY LIFE ACTIVITY; DRUG DOSE INCREASE; HUMAN; IMMUNOMODULATION; LETTER; MALE; MULTIPLE CYCLE TREATMENT; PARAPROTEINEMIA; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 34547962671 PISSN: 00064971 EISSN: 00064971 Source Type: Journal
DOI: 10.1182/blood-2007-03-082354 Document Type: Letter

Times cited : (96)

References (9)

1
- 0036839013
- Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
- Richardson PG, Schlossman RL, Weller E, et al. Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood. 2002;100:3063-3067.
- (2002) Blood , vol.100 , pp. 3063-3067
- Richardson, P.G.¹ Schlossman, R.L.² Weller, E.³

2
- 27744492561
- Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
- Rajkumar SV, Hayman SR, Lacy MQ, et al. Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma. Blood. 2005;106:4050-4053.
- (2005) Blood , vol.106 , pp. 4050-4053
- Rajkumar, S.V.¹ Hayman, S.R.² Lacy, M.Q.³

3
- 0030022090
- Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome
- Gherardi RK, Belec L, Soubrier M, et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood. 1996;87:1458-1465.
- (1996) Blood , vol.87 , pp. 1458-1465
- Gherardi, R.K.¹ Belec, L.² Soubrier, M.³

4
- 0031716986
- Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome
- Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve. 1998;21:1390-1397.
- (1998) Muscle Nerve , vol.21 , pp. 1390-1397
- Watanabe, O.¹ Maruyama, I.² Arimura, K.³

5
- 33747860292
- Thalidomide for POEMS syndrome
- Kim SY, Lee SA, Ryoo HM, Lee KH, Hyun MS, Bae SH. Thalidomide for POEMS syndrome. Ann Hematol. 2006;85:545-546.
- (2006) Ann Hematol , vol.85 , pp. 545-546
- Kim, S.Y.¹ Lee, S.A.² Ryoo, H.M.³ Lee, K.H.⁴ Hyun, M.S.⁵ Bae, S.H.⁶

6
- 20044386503
- Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma
- Tosi P, Zamagni E, Cellini C, et al. Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma. Eur J Haematol. 2005;74:212-216.
- (2005) Eur J Haematol , vol.74 , pp. 212-216
- Tosi, P.¹ Zamagni, E.² Cellini, C.³

7
- 8644260144
- Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature
- Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood. 2004;104:3400-3407.
- (2004) Blood , vol.104 , pp. 3400-3407
- Dispenzieri, A.¹ Moreno-Aspitia, A.² Suarez, G.A.³

8
- 23044513130
- Bevacizumab therapy for POEMS syndrome
- Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood. 2005;106:1135.
- (2005) Blood , vol.106 , pp. 1135
- Badros, A.¹ Porter, N.² Zimrin, A.³

9
- 85117738286
- Straume O, Bergheim J, Ernst P. Bevacizumab therapy for POEMS syndrome. Blood. 2006;107:4972-4973, author reply 4973-4974.
- Straume O, Bergheim J, Ernst P. Bevacizumab therapy for POEMS syndrome. Blood. 2006;107:4972-4973, author reply 4973-4974.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.